AM, S., KD, S., & B, B. (2020). Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press.
Style de citation Chicago (17e éd.)AM, Sigmund, Sahasrabudhe KD, et Bhatnagar B. Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)AM, Sigmund, et al. Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.